PharmaReports: Oncology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
Showing results 151 - 200 of 203
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
- Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Vaginal Cancer - Pipeline Review, H2 2011
- AIDS - Related Cancers - Pipeline Review, H2 2011
- Vulvar Cancer - Pipeline Review, H2 2011
- Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
- Plasma Cell Neoplasm - Pipeline Review, H2 2011
- Hypopharyngeal Cancer - Pipeline Review, H2 2011
- Squamous Cell Carcinoma - Pipeline Review, H2 2011
- Osteosarcoma - Pipeline Review, H2 2011
- Pediatric Cancer - Pipeline Review, H2 2011
- Thymus Cancer - Pipeline Review, H2 2011
- Lip And Oral Cavity Cancer - Pipeline Review, H2 2011
- Carcinoma Of The Bile Duct - Pipeline Review, H2 2011
- Metastatic Brain Tumors - Pipeline Review, H2 2011
- Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Miripla (Liver Cancer) – Analysis and Forecasts to 2020
- Gleevec (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- ThermoDox (Liver Cancer) – Analysis and Forecasts to 2020
- Doxorubicin (Liver Cancer) – Analysis and Forecasts to 2020
- Thalidomide (Liver Cancer) – Analysis and Forecasts to 2020
- Muparfostat (Liver Cancer) – Analysis and Forecasts to 2020
- PrevOnco (Liver Cancer) – Analysis and Forecasts to 2020
- Nexavar (Liver Cancer) – Analysis and Forecasts to 2020
- Avastin (Liver Cancer) – Analysis and Forecasts to 2020
- Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Tarceva (Liver Cancer) – Analysis and Forecasts to 2020
- Ramucirumab (Liver Cancer) – Analysis and Forecasts to 2020
- Linifanib (Liver Cancer) – Assessment and Forecasts to 2020
- Brivanib (Liver Cancer) – Analysis and Forecasts to 2020
- Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
- Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development